Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence.

Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, McEvoy M, Attia J, Levi C, Sturm J, Almeida OP, Yeap BB, Flicker L, Norman PE, Hankey GJ.

Stroke. 2014 Apr;45(4):1064-8. doi: 10.1161/STROKEAHA.113.004339. Epub 2014 Feb 25.

2.

Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.

Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L.

BMC Neurol. 2009 Apr 28;9:18. doi: 10.1186/1471-2377-9-18.

3.

The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke.

Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, Welsh P, Green A, Andrews M, Sandercock P.

Stroke. 2012 Jan;43(1):86-91. doi: 10.1161/STROKEAHA.111.634089. Epub 2011 Oct 20.

4.

Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.

Doehner W, von Haehling S, Suhr J, Ebner N, Schuster A, Nagel E, Melms A, Wurster T, Stellos K, Gawaz M, Bigalke B.

J Am Coll Cardiol. 2012 Jul 24;60(4):346-54. doi: 10.1016/j.jacc.2012.04.024.

5.

Higher on-admission serum triglycerides predict less severe disability and lower all-cause mortality after acute ischemic stroke.

Pikija S, Trkulja V, Juvan L, Ivanec M, Dukši D.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e15-24. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.006. Epub 2012 Apr 13.

PMID:
22503299
6.

Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.

Zhong C, Yang J, Xu T, Xu T, Peng Y, Wang A, Wang J, Peng H, Li Q, Ju Z, Geng D, Zhang Y, He J; CATIS Investigators.

Neurology. 2017 Aug 22;89(8):805-812. doi: 10.1212/WNL.0000000000004257. Epub 2017 Jul 26.

PMID:
28747453
7.

Mean platelet volume in acute phase of ischemic stroke, as predictor of mortality and functional outcome after 1 year.

Arévalo-Lorido JC, Carretero-Gómez J, Álvarez-Oliva A, Gutiérrez-Montaño C, Fernández-Recio JM, Najarro-Díez F.

J Stroke Cerebrovasc Dis. 2013 May;22(4):297-303. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.009. Epub 2011 Oct 17.

PMID:
22005035
8.

Progranulin and short-term outcome in patients with acute ischaemic stroke.

Xie S, Lu L, Liu L, Bi G, Zheng L.

Eur J Neurol. 2016 Mar;23(3):648-55. doi: 10.1111/ene.12920. Epub 2016 Jan 5.

PMID:
26728399
9.

Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS).

Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.

Metabolism. 2014 Sep;63(9):1093-103. doi: 10.1016/j.metabol.2014.04.012. Epub 2014 May 2.

PMID:
24929894
10.

Can Prediction of Functional Outcome after Stroke Be Improved by Adding Fibrinogen to Prognostic Model?

Swarowska M, Ferens A, Pera J, Slowik A, Dziedzic T.

J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2752-2755. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.029. Epub 2016 Aug 5.

PMID:
27503272
11.

Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.

Li S, Zhao X, Wang C, Liu L, Liu G, Wang Y, Wang C, Jing J, Wang YJ.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e419-25. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.025. Epub 2013 May 28.

PMID:
23721617
12.

Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.

Chakraborty B, Chowdhury D, Vishnoi G, Goswami B, Kishore J, Agarwal S.

J Stroke Cerebrovasc Dis. 2013 Jul;22(5):683-9. doi: 10.1016/j.jstrokecerebrovasdis.2012.02.007. Epub 2012 Mar 10.

PMID:
22410655
13.
14.

Association of plasma brain natriuretic peptide levels in acute ischemic stroke subtypes and outcome.

Chaudhuri JR, Sharma VK, Mridula KR, Balaraju B, Bandaru VC.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):485-91. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.025. Epub 2014 Dec 16.

PMID:
25524015
15.

Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.

Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Matetzky S, Adler Y, Mekori YA, Behar S.

Stroke. 2002 Sep;33(9):2182-6.

16.

C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.

Naess H, Nyland H, Idicula T, Waje-Andreassen U.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e435-40. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.031. Epub 2013 Jun 2.

PMID:
23735372
17.

Prognostic significance of plasma visfatin levels in patients with ischemic stroke.

Yin CG, Jiang L, Tang B, Zhang H, Qian Q, Niu GZ.

Peptides. 2013 Apr;42:101-4. doi: 10.1016/j.peptides.2013.01.005. Epub 2013 Jan 15.

PMID:
23328215
18.

Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke.

Swarowska M, Polczak A, Pera J, Klimkowicz-Mrowiec A, Slowik A, Dziedzic T.

J Thromb Thrombolysis. 2014 Nov;38(4):517-21. doi: 10.1007/s11239-014-1122-1.

19.

Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke.

Park KY, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, Kim JM, Youn YC, Kwon OS.

Cerebrovasc Dis. 2015;40(1-2):73-80. doi: 10.1159/000434691. Epub 2015 Jul 11.

PMID:
26184826
20.

Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis.

Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC.

Crit Care Med. 2011 Apr;39(4):702-10. doi: 10.1097/CCM.0b013e318206d285.

PMID:
21242795

Supplemental Content

Support Center